
pmid: 19687715
Calcium channel blockers continue to be used for the management of a wide variety of adult and pediatric conditions including hypertension, angina pectoris, atrial arrhythmias, Raynaud phenomenon, and migraine headaches. With increased use comes increased potential for misuse and abuse. This article serves as a review of calcium channel blocker physiology with emphasis on presentation and management of the pediatric patient with calcium channel blocker toxicity.
Adult, Extracorporeal Circulation, Fat Emulsions, Intravenous, Calcium Channels, L-Type, Infant, Cardiovascular Agents, Enema, Heart, Calcium Channel Blockers, Glucagon, Combined Modality Therapy, Calcium Chloride, Cardiovascular Diseases, Charcoal, Child, Preschool, Hyperglycemia, Fluid Therapy, Humans, Assisted Circulation, Drug Overdose
Adult, Extracorporeal Circulation, Fat Emulsions, Intravenous, Calcium Channels, L-Type, Infant, Cardiovascular Agents, Enema, Heart, Calcium Channel Blockers, Glucagon, Combined Modality Therapy, Calcium Chloride, Cardiovascular Diseases, Charcoal, Child, Preschool, Hyperglycemia, Fluid Therapy, Humans, Assisted Circulation, Drug Overdose
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 26 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
